English
简体中文
Total: £ 56.28
Published Date: 2025-09-17 | Pages: 106 | Tables: 104 | Medical Care
The global Pharmaceutical Contract Sales Outsourcing (CSO) market size was US$ 8683 million in 2024 and is forecast to a readjusted size of US$ 13920 million by 2031 with a CAGR of 7.1% during the forecast period 2025-2031.
Pharmaceutical Contract Sales Outsourcing (CSO), also known as Contract Sales Organization (CSO),means an Entity commonly and primarily known as a "contract sales organization" that is engaged primarily in the business of promoting products for third parties and is not, and is not a direct or indirect affiliate of, an entity commonly and primarily known as a "pharmaceutical", "biopharmaceutical" or "biotechnology" company; and (2) "Contract Sales Arrangement" shall mean an arrangement (that is terminable by the Company within three years without payment or penalty) between the Company and a Contract Sales Organization under which such Contract Sales Organization (A) would promote (and would only be granted such rights as are necessary to promote) a Company Pharmaceutical Product for a fee (which may be fixed or based upon a percentage of revenues or otherwise) but (B) would not be granted any research, development, manufacturing, sublicensing or other rights with respect to such Company Pharmaceutical Product or with respect to any Intellectual Property underlying or related to such Company Pharmaceutical Product except as necessary for the purpose of clause "(A)".
The Pharmaceutical Contract Sales Outsourcing (CSO) market covers Personal Promotion, Non-personal Promotion, Others, etc. The typical players include IQVIA, PHOENIX Group, Amplity Health, Ashfield Engage (Inizio), Syneos Health, EVERSANA, CMIC Group, EPS Corporation, etc.
Global key players of pharmaceutical contract sales outsourcing include China Medical System (CMS), IQVIA, PHOENIX Group, EVERSANA, etc. The top five players hold a share over 40%.
The global Pharmaceutical Contract Sales Outsourcing (CSO) market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
China Medical System (CMS)
IQVIA
PHOENIX Group
EVERSANA
Ashfield Engage (Inizio)
Amplity Health
Sinco Pharma
Syneos Health
EPS Corporation
Uniphar Group
CMIC Group
SciClone Pharmaceuticals
China Pioneer Pharma
Promoveo Health
CSO Pharmitalia
GTS Solution
QFR Solutions
By Type: (Dominant Segment vs High-Margin Innovation)
Personal Promotion
Non-personal Promotion
Others
By Application: (Core Demand Driver vs Emerging Opportunity)
Pharmaceutical Company
Biotechnology Company
Generic Company
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., China Medical System (CMS) in Europe)
- Emerging Product Trends: Personal Promotion adoption vs. Non-personal Promotion premiumization
- Demand-Side Dynamics: Pharmaceutical Company growth in China vs. Biotechnology Company potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Pharmaceutical Contract Sales Outsourcing (CSO) market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Non-personal Promotion in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Biotechnology Company in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Pharmaceutical Contract Sales Outsourcing (CSO) value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Personal Promotion
1.2.3 Non-personal Promotion
1.2.4 Others
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Company
1.3.3 Biotechnology Company
1.3.4 Generic Company
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Pharmaceutical Contract Sales Outsourcing (CSO) Revenue Market Share by Region (2020-2025)
2.4 Global Pharmaceutical Contract Sales Outsourcing (CSO) Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Pharmaceutical Contract Sales Outsourcing (CSO) Market Size and Prospective (2020-2031)
2.5.2 Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Size and Prospective (2020-2031)
2.5.3 China Pharmaceutical Contract Sales Outsourcing (CSO) Market Size and Prospective (2020-2031)
2.5.4 Japan Pharmaceutical Contract Sales Outsourcing (CSO) Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Pharmaceutical Contract Sales Outsourcing (CSO) Historic Market Size by Type (2020-2025)
3.2 Global Pharmaceutical Contract Sales Outsourcing (CSO) Forecasted Market Size by Type (2026-2031)
3.3 Different Types Pharmaceutical Contract Sales Outsourcing (CSO) Representative Players
4 Breakdown Data by Application
4.1 Global Pharmaceutical Contract Sales Outsourcing (CSO) Historic Market Size by Application (2020-2025)
4.2 Global Pharmaceutical Contract Sales Outsourcing (CSO) Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Pharmaceutical Contract Sales Outsourcing (CSO) Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Pharmaceutical Contract Sales Outsourcing (CSO) Players by Revenue (2020-2025)
5.1.2 Global Pharmaceutical Contract Sales Outsourcing (CSO) Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Pharmaceutical Contract Sales Outsourcing (CSO) Revenue
5.4 Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Concentration Analysis
5.4.1 Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Contract Sales Outsourcing (CSO) Revenue in 2024
5.5 Global Key Players of Pharmaceutical Contract Sales Outsourcing (CSO) Head office and Area Served
5.6 Global Key Players of Pharmaceutical Contract Sales Outsourcing (CSO), Product and Application
5.7 Global Key Players of Pharmaceutical Contract Sales Outsourcing (CSO), Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Pharmaceutical Contract Sales Outsourcing (CSO) Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Type (2020-2025)
6.1.2.2 North America Pharmaceutical Contract Sales Outsourcing (CSO) Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Application (2020-2025)
6.1.3.2 North America Pharmaceutical Contract Sales Outsourcing (CSO) Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Pharmaceutical Contract Sales Outsourcing (CSO) Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Type (2020-2025)
6.2.2.2 Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Application (2020-2025)
6.2.3.2 Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Pharmaceutical Contract Sales Outsourcing (CSO) Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Type (2020-2025)
6.3.2.2 China Pharmaceutical Contract Sales Outsourcing (CSO) Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Application (2020-2025)
6.3.3.2 China Pharmaceutical Contract Sales Outsourcing (CSO) Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Pharmaceutical Contract Sales Outsourcing (CSO) Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Type (2020-2025)
6.4.2.2 Japan Pharmaceutical Contract Sales Outsourcing (CSO) Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Application (2020-2025)
6.4.3.2 Japan Pharmaceutical Contract Sales Outsourcing (CSO) Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
7 Key Players Profiles
7.1 China Medical System (CMS)
7.1.1 China Medical System (CMS) Company Details
7.1.2 China Medical System (CMS) Business Overview
7.1.3 China Medical System (CMS) Pharmaceutical Contract Sales Outsourcing (CSO) Introduction
7.1.4 China Medical System (CMS) Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2020-2025)
7.1.5 China Medical System (CMS) Recent Development
7.2 IQVIA
7.2.1 IQVIA Company Details
7.2.2 IQVIA Business Overview
7.2.3 IQVIA Pharmaceutical Contract Sales Outsourcing (CSO) Introduction
7.2.4 IQVIA Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2020-2025)
7.2.5 IQVIA Recent Development
7.3 PHOENIX Group
7.3.1 PHOENIX Group Company Details
7.3.2 PHOENIX Group Business Overview
7.3.3 PHOENIX Group Pharmaceutical Contract Sales Outsourcing (CSO) Introduction
7.3.4 PHOENIX Group Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2020-2025)
7.3.5 PHOENIX Group Recent Development
7.4 EVERSANA
7.4.1 EVERSANA Company Details
7.4.2 EVERSANA Business Overview
7.4.3 EVERSANA Pharmaceutical Contract Sales Outsourcing (CSO) Introduction
7.4.4 EVERSANA Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2020-2025)
7.4.5 EVERSANA Recent Development
7.5 Ashfield Engage (Inizio)
7.5.1 Ashfield Engage (Inizio) Company Details
7.5.2 Ashfield Engage (Inizio) Business Overview
7.5.3 Ashfield Engage (Inizio) Pharmaceutical Contract Sales Outsourcing (CSO) Introduction
7.5.4 Ashfield Engage (Inizio) Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2020-2025)
7.5.5 Ashfield Engage (Inizio) Recent Development
7.6 Amplity Health
7.6.1 Amplity Health Company Details
7.6.2 Amplity Health Business Overview
7.6.3 Amplity Health Pharmaceutical Contract Sales Outsourcing (CSO) Introduction
7.6.4 Amplity Health Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2020-2025)
7.6.5 Amplity Health Recent Development
7.7 Sinco Pharma
7.7.1 Sinco Pharma Company Details
7.7.2 Sinco Pharma Business Overview
7.7.3 Sinco Pharma Pharmaceutical Contract Sales Outsourcing (CSO) Introduction
7.7.4 Sinco Pharma Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2020-2025)
7.7.5 Sinco Pharma Recent Development
7.8 Syneos Health
7.8.1 Syneos Health Company Details
7.8.2 Syneos Health Business Overview
7.8.3 Syneos Health Pharmaceutical Contract Sales Outsourcing (CSO) Introduction
7.8.4 Syneos Health Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2020-2025)
7.8.5 Syneos Health Recent Development
7.9 EPS Corporation
7.9.1 EPS Corporation Company Details
7.9.2 EPS Corporation Business Overview
7.9.3 EPS Corporation Pharmaceutical Contract Sales Outsourcing (CSO) Introduction
7.9.4 EPS Corporation Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2020-2025)
7.9.5 EPS Corporation Recent Development
7.10 Uniphar Group
7.10.1 Uniphar Group Company Details
7.10.2 Uniphar Group Business Overview
7.10.3 Uniphar Group Pharmaceutical Contract Sales Outsourcing (CSO) Introduction
7.10.4 Uniphar Group Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2020-2025)
7.10.5 Uniphar Group Recent Development
7.11 CMIC Group
7.11.1 CMIC Group Company Details
7.11.2 CMIC Group Business Overview
7.11.3 CMIC Group Pharmaceutical Contract Sales Outsourcing (CSO) Introduction
7.11.4 CMIC Group Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2020-2025)
7.11.5 CMIC Group Recent Development
7.12 SciClone Pharmaceuticals
7.12.1 SciClone Pharmaceuticals Company Details
7.12.2 SciClone Pharmaceuticals Business Overview
7.12.3 SciClone Pharmaceuticals Pharmaceutical Contract Sales Outsourcing (CSO) Introduction
7.12.4 SciClone Pharmaceuticals Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2020-2025)
7.12.5 SciClone Pharmaceuticals Recent Development
7.13 China Pioneer Pharma
7.13.1 China Pioneer Pharma Company Details
7.13.2 China Pioneer Pharma Business Overview
7.13.3 China Pioneer Pharma Pharmaceutical Contract Sales Outsourcing (CSO) Introduction
7.13.4 China Pioneer Pharma Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2020-2025)
7.13.5 China Pioneer Pharma Recent Development
7.14 Promoveo Health
7.14.1 Promoveo Health Company Details
7.14.2 Promoveo Health Business Overview
7.14.3 Promoveo Health Pharmaceutical Contract Sales Outsourcing (CSO) Introduction
7.14.4 Promoveo Health Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2020-2025)
7.14.5 Promoveo Health Recent Development
7.15 CSO Pharmitalia
7.15.1 CSO Pharmitalia Company Details
7.15.2 CSO Pharmitalia Business Overview
7.15.3 CSO Pharmitalia Pharmaceutical Contract Sales Outsourcing (CSO) Introduction
7.15.4 CSO Pharmitalia Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2020-2025)
7.15.5 CSO Pharmitalia Recent Development
7.16 GTS Solution
7.16.1 GTS Solution Company Details
7.16.2 GTS Solution Business Overview
7.16.3 GTS Solution Pharmaceutical Contract Sales Outsourcing (CSO) Introduction
7.16.4 GTS Solution Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2020-2025)
7.16.5 GTS Solution Recent Development
7.17 QFR Solutions
7.17.1 QFR Solutions Company Details
7.17.2 QFR Solutions Business Overview
7.17.3 QFR Solutions Pharmaceutical Contract Sales Outsourcing (CSO) Introduction
7.17.4 QFR Solutions Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2020-2025)
7.17.5 QFR Solutions Recent Development
8 Pharmaceutical Contract Sales Outsourcing (CSO) Market Dynamics
8.1 Pharmaceutical Contract Sales Outsourcing (CSO) Industry Trends
8.2 Pharmaceutical Contract Sales Outsourcing (CSO) Market Drivers
8.3 Pharmaceutical Contract Sales Outsourcing (CSO) Market Challenges
8.4 Pharmaceutical Contract Sales Outsourcing (CSO) Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Pharmaceutical Contract Sales Outsourcing (CSO) Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Pharmaceutical Contract Sales Outsourcing (CSO) Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Pharmaceutical Contract Sales Outsourcing (CSO) Revenue Share by Region (2020-2025)
Table 6. Global Pharmaceutical Contract Sales Outsourcing (CSO) Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Pharmaceutical Contract Sales Outsourcing (CSO) Revenue Share Forecast by Region (2026-2031)
Table 8. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Pharmaceutical Contract Sales Outsourcing (CSO) Revenue Market Share by Type (2020-2025)
Table 10. Global Pharmaceutical Contract Sales Outsourcing (CSO) Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Pharmaceutical Contract Sales Outsourcing (CSO) Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Pharmaceutical Contract Sales Outsourcing (CSO) Revenue Market Share by Application (2020-2025)
Table 15. Global Pharmaceutical Contract Sales Outsourcing (CSO) Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Pharmaceutical Contract Sales Outsourcing (CSO) Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Pharmaceutical Contract Sales Outsourcing (CSO) Application
Table 18. Global Pharmaceutical Contract Sales Outsourcing (CSO) Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Share by Players (2020-2025)
Table 20. Global Top Pharmaceutical Contract Sales Outsourcing (CSO) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) as of 2024)
Table 21. Ranking of Global Top Pharmaceutical Contract Sales Outsourcing (CSO) Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Pharmaceutical Contract Sales Outsourcing (CSO) Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Pharmaceutical Contract Sales Outsourcing (CSO), Headquarters and Area Served
Table 24. Global Key Players of Pharmaceutical Contract Sales Outsourcing (CSO), Product and Application
Table 25. Global Key Players of Pharmaceutical Contract Sales Outsourcing (CSO), Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Pharmaceutical Contract Sales Outsourcing (CSO) Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Pharmaceutical Contract Sales Outsourcing (CSO) Revenue Market Share by Company (2020-2025)
Table 29. North America Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Pharmaceutical Contract Sales Outsourcing (CSO) Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Pharmaceutical Contract Sales Outsourcing (CSO) Revenue Market Share by Company (2020-2025)
Table 33. Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Pharmaceutical Contract Sales Outsourcing (CSO) Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Pharmaceutical Contract Sales Outsourcing (CSO) Revenue Market Share by Company (2020-2025)
Table 37. China Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Pharmaceutical Contract Sales Outsourcing (CSO) Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Pharmaceutical Contract Sales Outsourcing (CSO) Revenue Market Share by Company (2020-2025)
Table 41. Japan Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Application (2020-2025) & (US$ Million)
Table 43. China Medical System (CMS) Company Details
Table 44. China Medical System (CMS) Business Overview
Table 45. China Medical System (CMS) Pharmaceutical Contract Sales Outsourcing (CSO) Product
Table 46. China Medical System (CMS) Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2020-2025) & (US$ Million)
Table 47. China Medical System (CMS) Recent Development
Table 48. IQVIA Company Details
Table 49. IQVIA Business Overview
Table 50. IQVIA Pharmaceutical Contract Sales Outsourcing (CSO) Product
Table 51. IQVIA Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2020-2025) & (US$ Million)
Table 52. IQVIA Recent Development
Table 53. PHOENIX Group Company Details
Table 54. PHOENIX Group Business Overview
Table 55. PHOENIX Group Pharmaceutical Contract Sales Outsourcing (CSO) Product
Table 56. PHOENIX Group Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2020-2025) & (US$ Million)
Table 57. PHOENIX Group Recent Development
Table 58. EVERSANA Company Details
Table 59. EVERSANA Business Overview
Table 60. EVERSANA Pharmaceutical Contract Sales Outsourcing (CSO) Product
Table 61. EVERSANA Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2020-2025) & (US$ Million)
Table 62. EVERSANA Recent Development
Table 63. Ashfield Engage (Inizio) Company Details
Table 64. Ashfield Engage (Inizio) Business Overview
Table 65. Ashfield Engage (Inizio) Pharmaceutical Contract Sales Outsourcing (CSO) Product
Table 66. Ashfield Engage (Inizio) Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2020-2025) & (US$ Million)
Table 67. Ashfield Engage (Inizio) Recent Development
Table 68. Amplity Health Company Details
Table 69. Amplity Health Business Overview
Table 70. Amplity Health Pharmaceutical Contract Sales Outsourcing (CSO) Product
Table 71. Amplity Health Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2020-2025) & (US$ Million)
Table 72. Amplity Health Recent Development
Table 73. Sinco Pharma Company Details
Table 74. Sinco Pharma Business Overview
Table 75. Sinco Pharma Pharmaceutical Contract Sales Outsourcing (CSO) Product
Table 76. Sinco Pharma Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2020-2025) & (US$ Million)
Table 77. Sinco Pharma Recent Development
Table 78. Syneos Health Company Details
Table 79. Syneos Health Business Overview
Table 80. Syneos Health Pharmaceutical Contract Sales Outsourcing (CSO) Product
Table 81. Syneos Health Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2020-2025) & (US$ Million)
Table 82. Syneos Health Recent Development
Table 83. EPS Corporation Company Details
Table 84. EPS Corporation Business Overview
Table 85. EPS Corporation Pharmaceutical Contract Sales Outsourcing (CSO) Product
Table 86. EPS Corporation Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2020-2025) & (US$ Million)
Table 87. EPS Corporation Recent Development
Table 88. Uniphar Group Company Details
Table 89. Uniphar Group Business Overview
Table 90. Uniphar Group Pharmaceutical Contract Sales Outsourcing (CSO) Product
Table 91. Uniphar Group Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2020-2025) & (US$ Million)
Table 92. Uniphar Group Recent Development
Table 93. CMIC Group Company Details
Table 94. CMIC Group Business Overview
Table 95. CMIC Group Pharmaceutical Contract Sales Outsourcing (CSO) Product
Table 96. CMIC Group Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2020-2025) & (US$ Million)
Table 97. CMIC Group Recent Development
Table 98. SciClone Pharmaceuticals Company Details
Table 99. SciClone Pharmaceuticals Business Overview
Table 100. SciClone Pharmaceuticals Pharmaceutical Contract Sales Outsourcing (CSO) Product
Table 101. SciClone Pharmaceuticals Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2020-2025) & (US$ Million)
Table 102. SciClone Pharmaceuticals Recent Development
Table 103. China Pioneer Pharma Company Details
Table 104. China Pioneer Pharma Business Overview
Table 105. China Pioneer Pharma Pharmaceutical Contract Sales Outsourcing (CSO) Product
Table 106. China Pioneer Pharma Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2020-2025) & (US$ Million)
Table 107. China Pioneer Pharma Recent Development
Table 108. Promoveo Health Company Details
Table 109. Promoveo Health Business Overview
Table 110. Promoveo Health Pharmaceutical Contract Sales Outsourcing (CSO) Product
Table 111. Promoveo Health Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2020-2025) & (US$ Million)
Table 112. Promoveo Health Recent Development
Table 113. CSO Pharmitalia Company Details
Table 114. CSO Pharmitalia Business Overview
Table 115. CSO Pharmitalia Pharmaceutical Contract Sales Outsourcing (CSO) Product
Table 116. CSO Pharmitalia Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2020-2025) & (US$ Million)
Table 117. CSO Pharmitalia Recent Development
Table 118. GTS Solution Company Details
Table 119. GTS Solution Business Overview
Table 120. GTS Solution Pharmaceutical Contract Sales Outsourcing (CSO) Product
Table 121. GTS Solution Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2020-2025) & (US$ Million)
Table 122. GTS Solution Recent Development
Table 123. QFR Solutions Company Details
Table 124. QFR Solutions Business Overview
Table 125. QFR Solutions Pharmaceutical Contract Sales Outsourcing (CSO) Product
Table 126. QFR Solutions Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2020-2025) & (US$ Million)
Table 127. QFR Solutions Recent Development
Table 128. Pharmaceutical Contract Sales Outsourcing (CSO) Market Trends
Table 129. Pharmaceutical Contract Sales Outsourcing (CSO) Market Drivers
Table 130. Pharmaceutical Contract Sales Outsourcing (CSO) Market Challenges
Table 131. Pharmaceutical Contract Sales Outsourcing (CSO) Market Restraints
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Pharmaceutical Contract Sales Outsourcing (CSO) Product Picture
Figure 2. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Share by Type: 2024 VS 2031
Figure 3. Personal Promotion Features
Figure 4. Non-personal Promotion Features
Figure 5. Others Features
Figure 6. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Share by Application: 2024 VS 2031
Figure 7. Pharmaceutical Company
Figure 8. Biotechnology Company
Figure 9. Generic Company
Figure 10. Others
Figure 11. Pharmaceutical Contract Sales Outsourcing (CSO) Report Years Considered
Figure 12. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Pharmaceutical Contract Sales Outsourcing (CSO) Revenue Market Share by Region: 2020 VS 2024
Figure 15. North America Pharmaceutical Contract Sales Outsourcing (CSO) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Europe Pharmaceutical Contract Sales Outsourcing (CSO) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. China Pharmaceutical Contract Sales Outsourcing (CSO) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. Japan Pharmaceutical Contract Sales Outsourcing (CSO) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Share by Players in 2024
Figure 20. Global Top Pharmaceutical Contract Sales Outsourcing (CSO) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Pharmaceutical Contract Sales Outsourcing (CSO) Revenue in 2024
Figure 22. North America Pharmaceutical Contract Sales Outsourcing (CSO) Market Share by Type (2020-2025)
Figure 23. North America Pharmaceutical Contract Sales Outsourcing (CSO) Market Share by Application (2020-2025)
Figure 24. Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Share by Type (2020-2025)
Figure 25. Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Share by Application (2020-2025)
Figure 26. China Pharmaceutical Contract Sales Outsourcing (CSO) Market Share by Type (2020-2025)
Figure 27. China Pharmaceutical Contract Sales Outsourcing (CSO) Market Share by Application (2020-2025)
Figure 28. Japan Pharmaceutical Contract Sales Outsourcing (CSO) Market Share by Type (2020-2025)
Figure 29. Japan Pharmaceutical Contract Sales Outsourcing (CSO) Market Share by Application (2020-2025)
Figure 30. China Medical System (CMS) Revenue Growth Rate in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2020-2025)
Figure 31. IQVIA Revenue Growth Rate in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2020-2025)
Figure 32. PHOENIX Group Revenue Growth Rate in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2020-2025)
Figure 33. EVERSANA Revenue Growth Rate in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2020-2025)
Figure 34. Ashfield Engage (Inizio) Revenue Growth Rate in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2020-2025)
Figure 35. Amplity Health Revenue Growth Rate in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2020-2025)
Figure 36. Sinco Pharma Revenue Growth Rate in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2020-2025)
Figure 37. Syneos Health Revenue Growth Rate in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2020-2025)
Figure 38. EPS Corporation Revenue Growth Rate in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2020-2025)
Figure 39. Uniphar Group Revenue Growth Rate in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2020-2025)
Figure 40. CMIC Group Revenue Growth Rate in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2020-2025)
Figure 41. SciClone Pharmaceuticals Revenue Growth Rate in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2020-2025)
Figure 42. China Pioneer Pharma Revenue Growth Rate in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2020-2025)
Figure 43. Promoveo Health Revenue Growth Rate in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2020-2025)
Figure 44. CSO Pharmitalia Revenue Growth Rate in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2020-2025)
Figure 45. GTS Solution Revenue Growth Rate in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2020-2025)
Figure 46. QFR Solutions Revenue Growth Rate in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2020-2025)
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed
